Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Zakarya (Marrickville, NSW, Australia). Epigenetic control of TGFß induced fibrosis in COPD. 961

Member's Comments

No comment yet.

Related content which might interest you: Aberrant expression and activity of histone deacetylases in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 The role of the epigenetic regulator HMGN5 in COPD resulting from chronic lung injury Source: ERS Lung Science Conference 2017 Year: 2017 Presence of progranulin in airway inflammation associated with COPD Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Altered epigenetic features in circulating nucleosomes in idiopathic pulmonary fibrosis Source: International Congress 2017 – Rare diseases Year: 2017 IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Inhibition of profibrotic signaling in fibroblasts from patients with idiopathic pulmonary fibrosis (IPF) by histone deacetylase-inhibitors (HDACi) or the IPF drug pirfenidone Source: International Congress 2014 – ILDs 1 Year: 2014 The role of circulating mitochondrial DNA in modulating airway inflammation of chronic obstructive pulmonary disease Source: International Congress 2014 – Cell biology 2014 Year: 2014 Targeting the epigenome in asthma and COPD Source: Annual Congress 2013 –PG6 Epigenetics of asthma and COPD Year: 2013 Increased lung apoptosis and expression of ceramide in subjects with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009 Reactivation of developmental pathways in idiopathic pulmonary fibrosis: FGF9 and FGF18 modulate the phenotype of control and fibrotic human lung fibroblasts in vitro Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Age-dependent systemic elastin degradation is enhanced in chronic obstructive pulmonary disease Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 The EvA-Study: Markers of emphysema versus airway disease in COPD Source: Annual Congress 2009 - EU Research Programmes: 1.GABRIEL 2.EvA 3.COPACETIC Year: 2009 Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Myofibroblast expression in airways and alveoli is affected by smoking and COPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Dysregulation of serum miRNA in chronic obstructive pulmonary disease Source: International Congress 2015 – Genetics, genomics and exposures in asthma and COPD Year: 2015 Epigenetic regulation via PRMT7 controls monocyte migration and COPD pathogenesis Source: Virtual Congress 2021 – COPD pharmacology: from basic science to real-world data Year: 2021 microRNA-223 suppresses histone deacetylase 2 in chronic obstructive pulmonary disease Source: International Congress 2015 – Latest news on miRNAs in pulmonary research Year: 2015 Transcriptomic and epigenetic changes in the lung of patients with severe COPD Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 Mechanisms of treatment response to pirfenidone of idiopathic pulmonary fibrosis (IPF) patients Source: International Congress 2016 – IPF pathogenesis Year: 2016